The importance of hepatic functional reserve in sequential therapy with molecular targeted agents for advanced hepatocellular carcinoma １) Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and  candidates for regorafenib treatment in real-world practice 2) Trends in hepatic functional reserve of patients with hepatocellular carcinoma treated with tyrosine kinase inhibitors

k8332_1

WEKO3

lat lon distance

[[sub_check.contents]]

[[sub_radio.contents]]

Field does not validate

[[sub_attr.contents]]　

k8332_1.pdf

https://hiroshima.repo.nii.ac.jp/record/2002790/files/k8332_1.pdf

ファイル	ライセンス
k8332_1.pdf (196.4 kB) sha256 fe46bff7d8ed93e7650532836a7b89f3e97fac7a7de914146885bdfa0fc10a0a

Version	Date Modified	Object File Name	File Size	File Hash Value	Contributor Name	Show/Hide

Downloads

Plays